-There was NO significant difference in survival or recurrence between groups
In particular, this patient experienced worsening heart failure while discontinuing SGLT2 inhibitor
Both improve glucose control through paired mechanisms semaglutide through enhanced insulin secretion and suppressed glucagon, cagrilintide through reduced postprandial glucagon and enhanced leptin response
Given this uncertainty and the importance of infant nutrition, avoid Retatrutide while breastfeeding
5 Targeting BA metabolism for NAFLD therapy Targeting BA metabolism has become a promising therapeutic strategy for NAFLD due to the significant impact of BA on host metabolism, energy expenditure, inflammation, and the composition of the gut microbiota
Retatrutide is an investigational metabolic peptide designed as a triple-receptor agonist , simultaneously targeting: GIP receptors Glucagon receptors This multi-pathway approach aims to address obesity and metabolic dysfunction by influencing appetite regulation, insulin sensitivity, and energy expenditure
